StepStone Group LP
13F filer · CIK 0001502287Reported Aug 13, 2026
13F portfolio value$2.16BU.S. long equity reported on 13F
Positions23Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight99.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 202623 positions | |||||
| $1.87B | 86.62% | Not reported | New | Q2 2026 | |
| $97.3M | 4.51% | Not reported | Not reported | Q3 2025 | |
| $75.2M | 3.48% | Not reported | New | Q2 2026 | |
| $41.4M | 1.92% | 1.15% | New | Q2 2026 | |
| $16.4M | 0.76% | 2.78% | New | Q2 2026 | |
| $12.1M | 0.56% | 6.59% | Not reported | Q4 2024 | |
| $12M | 0.56% | 0.18% | Not reported | Q3 2025 | |
| $7.18M | 0.33% | 0.73% | Not reported | Q3 2025 | |
| $5.6M | 0.26% | 1.96% | Not reported | Q4 2021 | |
| $5.16M | 0.24% | 0.73% | New | Q2 2026 | |
| $4.58M | 0.21% | 0.53% | Not reported | Q3 2021 | |
| $3.07M | 0.14% | 0.22% | Not reported | Q3 2025 | |
| $2.67M | 0.12% | 0.04% | New | Q2 2026 | |
| $1.84M | 0.09% | 0.01% | Not reported | Q1 2020 | |
| $1.33M | 0.06% | 0.13% | Not reported | Q4 2025 | |
| $788K | 0.04% | Not reported | Not reported | Q3 2025 | |
| $748K | 0.03% | 0.00% | Not reported | Q1 2024 | |
| $476K | 0.02% | 0.91% | Not reported | Q2 2022 | |
| $342K | 0.02% | 0.21% | Not reported | Q3 2021 | |
| $290K | 0.01% | 0.13% | Not reported | Q3 2025 | |
| $138K | 0.01% | Not reported | Not reported | Q4 2025 | |
| $78.8K | 0.00% | 0.00% | New | Q2 2026 | |
| $4.82K | 0.00% | Not reported | Not reported | Q1 2025 | |
| Q4 2025Reported Feb 17, 202623 positions | |||||
| $102M | 54.74% | Not reported | Not reported | Q3 2025 | |
| $15.4M | 8.26% | 0.81% | Not reported | Q3 2025 | |
| $14.8M | 7.92% | Not reported | -29.8% | Q3 2021 | |
| $12.4M | 6.65% | 0.66% | +200.0% | Q3 2025 | |
| $7.83M | 4.19% | 1.99% | Not reported | Q4 2021 | |
| $7.29M | 3.90% | 0.93% | New | Q4 2025 | |
| $5.54M | 2.97% | Not reported | Not reported | Q4 2021 | |
| $4.97M | 2.66% | 0.59% | Not reported | Q3 2021 | |
| $3.38M | 1.81% | Not reported | New | Q4 2025 | |
| $2.82M | 1.51% | Not reported | Not reported | Q3 2025 | |
| $2.39M | 1.28% | 0.00% | New | Q4 2025 | |
| $1.86M | 1.00% | 0.22% | Not reported | Q3 2025 | |
| $1.41M | 0.75% | Not reported | Not reported | Q1 2025 | |
| $1.35M | 0.72% | 147.13% | Not reported | Q4 2024 | |
| $742K | 0.40% | Not reported | New | Q4 2025 | |
| $562K | 0.30% | 0.00% | New | Q4 2025 | |
| $476K | 0.25% | 0.00% | New | Q4 2025 | |
| $419K | 0.22% | 0.92% | Not reported | Q2 2022 | |
| $400K | 0.21% | 0.13% | Not reported | Q3 2025 | |
| $328K | 0.18% | 0.21% | Not reported | Q3 2021 | |
| $127K | 0.07% | 0.04% | New | Q4 2025 | |
| $26.3K | 0.01% | Not reported | -64.0% | Q3 2025 | |
| $3.22K | 0.00% | 0.00% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202516 positions | |||||
| $127M | 59.88% | Not reported | New | Q3 2025 | |
| $21.1M | 9.93% | 0.22% | New | Q3 2025 | |
| $17.2M | 8.09% | Not reported | Not reported | Q3 2021 | |
| $11.2M | 5.27% | Not reported | New | Q3 2025 | |
| $9.66M | 4.54% | 0.81% | New | Q3 2025 | |
| $6.02M | 2.83% | Not reported | Not reported | Q4 2021 | |
| $4.97M | 2.34% | 0.59% | Not reported | Q3 2021 | |
| $4.42M | 2.08% | 1.99% | Not reported | Q4 2021 | |
| NNEUENeuehealth, Inc. | $3.5M | 1.65% | 5.82% | Not reported | Q2 2023 |
| $3.03M | 1.42% | 0.22% | New | Q3 2025 | |
| $1.35M | 0.64% | 147.13% | Not reported | Q4 2024 | |
| $769K | 0.36% | 0.13% | New | Q3 2025 | |
| $749K | 0.35% | 0.28% | Not reported | Q3 2021 | |
| $688K | 0.32% | 0.00% | New | Q3 2025 | |
| $571K | 0.27% | 0.93% | Not reported | Q2 2022 | |
| $76.7K | 0.04% | Not reported | New | Q3 2025 | |
| Q1 2025Reported May 14, 202515 positions | |||||
| $13.3M | 13.61% | Not reported | Not reported | Q3 2021 | |
| $7.12M | 7.32% | Not reported | -33.3% | Q4 2021 | |
| $6.88M | 7.07% | 2.01% | Not reported | Q4 2021 | |
| NNEUENeuehealth, Inc. | $3.55M | 3.65% | 5.88% | Not reported | Q2 2023 |
| $3.28M | 3.37% | Not reported | New | Q1 2025 | |
| $2.65M | 2.72% | 0.61% | Not reported | Q3 2021 | |
| $2.12M | 2.17% | 147.13% | Not reported | Q4 2024 | |
| $2.03M | 2.08% | 0.11% | Not reported | Q4 2023 | |
| HHLVXHillevax, Inc. | $1.2M | 1.23% | 1.65% | Not reported | Q2 2022 |
| VVCSAVacasa, Inc. | $792K | 0.81% | 14726.10% | Not reported | Q4 2021 |
| $601K | 0.62% | 0.03% | Not reported | Q1 2022 | |
| $514K | 0.53% | 0.95% | Not reported | Q2 2022 | |
| $435K | 0.45% | 0.00% | New | Q1 2025 | |
| $263K | 0.27% | 0.53% | Not reported | Q3 2021 | |
| $22.8K | 0.02% | Not reported | Not reported | Q3 2021 | |
Premium opens every quarter this fund has filed